GHRP-6 vs Ipamorelin

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

⚠️ Known Interaction
LOW Can be interchanged but not typically stacked; GHRP-6 causes more hunger.
GHRP-6Ipamorelin
CategoryPeptidesPeptides
Standard DoseResearch indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.Research indicates 200-300 mcg administered 1-3 times daily via subcutaneous injection.
TimingOn empty stomach, 30+ minutes before meals. Bedtime dose most important. The strong hunger effect makes pre-meal timing practical.Best administered at bedtime for synergy with natural GH peak. Also effective upon waking and post-workout. Always on empty stomach.
Cycle Duration8-16 week cycles.12-24 week cycles with 4-8 week breaks.
Evidence Levelmoderate_humanmoderate_human
A

GHRP-6

Peptides

Mechanism

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates GH release through activation of the growth hormone secretagogue receptor (GHS-R1a/ghrelin receptor) on pituitary somatotrophs. It acts via dual sites — pituitary and hypothalamic — possibly involving regulatory factors beyond GHRH and somatostatin. GHRP-6 also stimulates ghrelin-mediated appetite signaling, increases cortisol and prolactin release, and has demonstrated cytoprotective properties including cardioprotection.

Standard Dosing

Research indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.

Timing

On empty stomach, 30+ minutes before meals. Bedtime dose most important. The strong hunger effect makes pre-meal timing practical.

Cycle Duration

8-16 week cycles.

Side Effects

  • Intense hunger (primary distinguishing side effect)
  • Water retention
  • Cortisol elevation
  • Prolactin elevation
  • Tingling and numbness
  • Injection site pain

Contraindications

  • Active cancer
  • Obesity (significant appetite stimulation)
  • Cushing's syndrome
  • Pregnancy and breastfeeding

Best Stacking Partners

CJC-1295 (no DAC)Sermorelin
B

Ipamorelin

Peptides

Mechanism

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts as the first selective growth hormone secretagogue receptor (GHS-R1a/ghrelin receptor) agonist. Unlike other GHRPs, it selectively stimulates GH release without significantly affecting ACTH, cortisol, prolactin, or aldosterone — even at doses 200-fold above the ED50 for GH release. This selectivity profile is comparable to GHRH itself but operates through the distinct ghrelin receptor on pituitary somatotrophs.

Standard Dosing

Research indicates 200-300 mcg administered 1-3 times daily via subcutaneous injection.

Timing

Best administered at bedtime for synergy with natural GH peak. Also effective upon waking and post-workout. Always on empty stomach.

Cycle Duration

12-24 week cycles with 4-8 week breaks.

Side Effects

  • Head rush post-injection
  • Mild hunger increase (less than GHRP-6)
  • Water retention (mild)
  • Tingling in extremities
  • Injection site irritation

Contraindications

  • Active cancer
  • Diabetic retinopathy
  • Pregnancy and breastfeeding

Best Stacking Partners

CJC-1295 (no DAC)BPC-157TB-500

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →